First American Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.7M | Sell |
18,167
-5,855
| -24% | -$5.94M | 1.12% | 24 |
|
|
2025
Q4 | $25.8M | Sell |
24,022
-2,847
| -11% | -$2.72M | 1.77% | 10 |
|
|
2025
Q3 | $20.5M | Sell |
26,869
-863
| -3% | -$642K | 1.49% | 13 |
|
|
2025
Q2 | $21.6M | Sell |
27,732
-3,254
| -11% | -$2.53M | 1.73% | 10 |
|
|
2025
Q1 | $25.6M | Buy |
30,986
+1,856
| +6% | +$1.54M | 2.35% | 6 |
|
|
2024
Q4 | $22.5M | Sell |
29,130
-376
| -1% | -$311K | 2.24% | 7 |
|
|
2024
Q3 | $26.1M | Buy |
29,506
+437
| +2% | +$393K | 2.59% | 5 |
|
|
2024
Q2 | $26.3M | Buy |
29,069
+186
| +0.6% | +$149K | 2.64% | 7 |
|
|
2024
Q1 | $22.5M | Buy |
28,883
+2,058
| +8% | +$1.46M | 2.36% | 7 |
|
|
2023
Q4 | $15.6M | Sell |
26,825
-1,756
| -6% | -$1.02M | 1.94% | 11 |
|
|
2023
Q3 | $15.4M | Sell |
28,581
-3,469
| -11% | -$1.79M | 2.17% | 9 |
|
|
2023
Q2 | $15M | Buy |
32,050
+62
| +0.2% | +$26K | 2.07% | 9 |
|
|
2023
Q1 | $11M | Sell |
31,988
-8,200
| -20% | -$2.77M | 1.63% | 16 |
|
|
2022
Q4 | $14.7M | Buy |
40,188
+338
| +0.8% | +$120K | 2.28% | 8 |
|
|
2022
Q3 | $12.9M | Buy |
39,850
+397
| +1% | +$126K | 2.16% | 11 |
|
|
2022
Q2 | $12.8M | Buy |
39,453
+864
| +2% | +$259K | 2.02% | 11 |
|
|
2022
Q1 | $11.1M | Sell |
38,589
-6,161
| -14% | -$1.59M | 1.52% | 17 |
|
|
2021
Q4 | $12.4M | Buy |
44,750
+629
| +1% | +$159K | 1.69% | 16 |
|
|
2021
Q3 | $10.2M | Buy |
44,121
+1,491
| +3% | +$368K | 1.54% | 18 |
|
|
2021
Q2 | $9.78M | Buy |
42,630
+200
| +0.5% | +$40.2K | 1.54% | 16 |
|
|
2021
Q1 | $7.93M | Buy |
42,430
+13,570
| +47% | +$2.65M | 1.25% | 24 |
|
|
2020
Q4 | $4.87M | Buy |
28,860
+738
| +3% | +$110K | 0.81% | 44 |
|
|
2020
Q3 | $4.16M | Buy |
28,122
+15,574
| +124% | +$2.41M | 0.75% | 51 |
|
|
2020
Q2 | $2.06M | Buy |
12,548
+467
| +4% | +$71.7K | 0.4% | 69 |
|
|
2020
Q1 | $1.68M | Hold |
12,081
| – | – | 0.41% | 69 |
|
|
2019
Q4 | $1.59M | Sell |
12,081
-1,342
| -10% | -$156K | 0.3% | 72 |
|
|
2019
Q3 | $1.5M | Hold |
13,423
| – | – | 0.3% | 71 |
|
|
2019
Q2 | $1.49M | Hold |
13,423
| – | – | 0.31% | 73 |
|
|
2019
Q1 | $1.74M | Hold |
13,423
| – | – | 0.38% | 72 |
|
|
2018
Q4 | $1.55M | Hold |
13,423
| – | – | 0.39% | 71 |
|
|
2018
Q3 | $1.44M | Hold |
13,423
| – | – | 0.32% | 71 |
|
|
2018
Q2 | $1.15M | Sell |
13,423
-100
| -0.7% | -$8.21K | 0.27% | 77 |
|
|
2018
Q1 | $1.05M | Buy |
13,523
+100
| +0.7% | +$8.05K | 0.25% | 79 |
|
|
2017
Q4 | $1.13M | Hold |
13,423
| – | – | 0.28% | 75 |
|
|
2017
Q3 | $1.15M | Hold |
13,423
| – | – | 0.3% | 74 |
|
|
2017
Q2 | $1.1M | Buy |
+13,423
| New | +$1.1M | 0.31% | 75 |
|
Other funds holding LLY
VCM
VPM
First American Trust's LLY Position: Q1 2026 in Review
First American Trust reduced its Eli Lilly (LLY) stake by 24% in Q1 2026, selling an estimated $5.94M and leaving 18,167 shares worth $16.7M. The position accounts for 1.12% of the portfolio, ranked #24.
First American Trust first reported a position in LLY in Q2 2017 and has held it in 36 quarters since. The position peaked at $26.3M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- First American Trust held 18,167 shares of Eli Lilly worth $16.7M as of Q1 2026.
- First American Trust sold 5,855 Eli Lilly shares in Q1 2026, an estimated $5.94M.
- Eli Lilly made up 1.12% of First American Trust's portfolio in Q1 2026, its #24 holding.
- First American Trust first reported a position in Eli Lilly in Q2 2017 and has held it in 36 quarters since.
- First American Trust's Eli Lilly position peaked at $26.3M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on First American Trust's 13F filing for Q1 2026, filed 12 May 2026.